相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Time for a Fully Integrated Nonclinical-Clinical Risk Assessment to Streamline QT Prolongation Liability Determinations: A Pharma Industry Perspective
Hugo M. Vargas et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)
Translational Models and Tools to Reduce Clinical Trials and Improve Regulatory Decision Making for QTc and Proarrhythmia Risk (ICH E14/S7B Updates)
David G. Strauss et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)
The roles of human induced pluripotent stem cell-derived cardiomyocytes in drug discovery: managing in vitro safety study expectations
Gary Gintant et al.
EXPERT OPINION ON DRUG DISCOVERY (2020)
A Bayesian approach to toxicological testing
James C. Felli et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2020)
Repolarization studies using human stem cell-derived cardiomyocytes: Validation studies and best practice recommendations
Gary Gintant et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2020)
Electrophysiological characterization of drug response in hSC-derived cardiomyocytes using voltage-sensitive optical platforms
Emily R. Pfeiffer-Kaushik et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2019)
Considerations for an In Vitro, Cell-Based Testing Platform for Detection of Drug-Induced Inotropic Effects in Early Drug Development. Part 2: Designing and Fabricating Microsystems for Assaying Cardiac Contractility With Physiological Relevance Using Human iPSC-Cardiomyocytes
Alexandre J. S. Ribeiro et al.
FRONTIERS IN PHARMACOLOGY (2019)
Resolving the Reversed Rate Effect of Calcium Channel Blockers on Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes and the Impact on In Vitro Cardiac Safety Evaluation
Haoyu Zeng et al.
TOXICOLOGICAL SCIENCES (2019)
Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes as Models for Cardiac Channelopathies: A Primer for Non-Electrophysiologists
Priyanka Garg et al.
CIRCULATION RESEARCH (2018)
Cross-Site Reliability of Human Induced Pluripotent stem cell-derived Cardiomyocyte Based Safety Assays Using Microelectrode Arrays: Results from a Blinded CiPA Pilot Study
Daniel Millard et al.
TOXICOLOGICAL SCIENCES (2018)
Biophysical comparison of sodium currents in native cardiac myocytes and human induced pluripotent stem cell-derived cardiomyocytes
Robert J. Goodrow et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2018)
International Multisite Study of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Drug Proarrhythmic Potential Assessment
Ksenia Blinova et al.
CELL REPORTS (2018)
Development of torsadogenic risk assessment using human induced pluripotent stem cell-derived cardiomyocytes: Japan iPS Cardiac Safety Assessment (JiCSA) update
Yasunari Kanda et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2018)
Comprehensive Translational Assessment of Human-Induced Pluripotent Stem Cell Derived Cardiomyocytes for Evaluating Drug-Induced Arrhythmias
Ksenia Blinova et al.
TOXICOLOGICAL SCIENCES (2017)
A new paradigm for drug-induced torsadogenic risk assessment using human iPS cell-derived cardiomyocytes
Hiroyuki Ando et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2017)
Adult Human Primary Cardiomyocyte-Based Model for the Simultaneous Prediction of Drug-Induced Inotropic and Pro-arrhythmia Risk
Nathalie Nguyen et al.
FRONTIERS IN PHYSIOLOGY (2017)
Correlation between human ether-a-go-go-related gene channel inhibition and action potential prolongation
P. Saxena et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
Improved Prediction of Drug-Induced Torsades de Pointes Through Simulations of Dynamics and Machine Learning Algorithms
M. Cummins Lancaster et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2016)
Comparison of electrophysiological effects of calcium channel blockers on cardiac repolarization
Hyang-Ae Lee et al.
KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY (2016)
Electrophysiological Characteristics of Human iPSC-Derived Cardiomyocytes for the Assessment of Drug-Induced Proarrhythmic Potential
Wataru Yamamoto et al.
PLOS ONE (2016)
Human ex-vivo action potential model for pro-arrhythmia risk assessment
Guy Page et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2016)
The Comprehensive in Vitro Proarrhythmia Assay (CiPA) initiative Update on progress
Thomas Colatsky et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2016)
A New Perspective in the Field of Cardiac Safety Testing through the Comprehensive In Vitro Proarrhythmia Assay Paradigm
Bernard Fermini et al.
JOURNAL OF BIOMOLECULAR SCREENING (2016)
A Photostable Silicon Rhodamine Platform for Optical Voltage Sensing
Yi-Lin Huang et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2015)
Differentiating Drug-Induced Multichannel Block on the Electrocardiogram: Randomized Study of Dofetilide, Quinidine, Ranolazine, and Verapamil
L. Johannesen et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2014)
Human-induced pluripotent stem cell-derived cardiomyocytes exhibit temporal changes in phenotype
Christine Y. Ivashchenko et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2013)
Comparison of Electrophysiological Data From Human-Induced Pluripotent Stem CellDerived Cardiomyocytes to Functional Preclinical Safety Assays
Kate Harris et al.
TOXICOLOGICAL SCIENCES (2013)
High purity human-induced pluripotent stem cell-derived cardiomyocytes: electrophysiological properties of action potentials and ionic currents
Junyi Ma et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2011)
On the relationship between block of the cardiac Na+ channel and drug-induced prolongation of the QRS complex
A. R. Harmer et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Simulation of the Undiseased Human Cardiac Ventricular Action Potential: Model Formulation and Experimental Validation
Thomas O'Hara et al.
PLOS COMPUTATIONAL BIOLOGY (2011)
Regularization Paths for Generalized Linear Models via Coordinate Descent
Jerome Friedman et al.
JOURNAL OF STATISTICAL SOFTWARE (2010)
Local Control of Excitation-Contraction Coupling in Human Embryonic Stem Cell-Derived Cardiomyocytes
Wei-Zhong Zhu et al.
PLOS ONE (2009)
Drug therapy: Drug-induced prolongation of the QT interval
DM Roden
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Role of the cytosolic chaperones Hsp70 and Hsp90 in maturation of the cardiac potassium channel hERG
E Ficker et al.
CIRCULATION RESEARCH (2003)
Genetic control of sodium channel function
HL Tan et al.
CARDIOVASCULAR RESEARCH (2003)
分享论文
